Enhabit EVP granted 6,724 EHAB shares in Form 4/A

Enhabit, Inc. executive Jeanne Louise Kalvaitis, EVP of Hospice Operations, reported an amended Form 4 reflecting a prior stock award.

Accepted by SEC EDGAR 03/11/2026 - 09:13 PM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

4/A

Rhea-AI Filing Summary

Enhabit, Inc. executive Jeanne Louise Kalvaitis, EVP of Hospice Operations, reported an amended Form 4 reflecting a prior stock award. She acquired 6,724 shares of common stock as a grant at a price of $13.61 per share. Following this acquisition, she directly holds 61,875 common shares. A footnote explains the award was omitted from the original filing due to a clerical error, and this amendment corrects that omission.

Insider Trade Summary

Grant/Award: 6,724 shares

Grant/Award 1 txn

Insider Kalvaitis Jeanne Louise

Role EVP of Hospice Operations

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	6,724	$13.61	$92K

Holdings After Transaction: Common Stock — 61,875 shares (Direct)

Holdings Before and After: Common Stock, 55,151 to 61,875 shares (Direct)

Footnotes (1)

F1. Due to a clerical error, this award was omitted from the original filing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Enhabit (EHAB) report for Jeanne Louise Kalvaitis?

Enhabit reported that EVP of Hospice Operations Jeanne Louise Kalvaitis acquired 6,724 shares of common stock. The shares were received as a grant at $13.61 per share and are recorded as a direct ownership position in her Form 4/A filing.

Is the Enhabit (EHAB) Form 4/A for Jeanne Kalvaitis a new transaction or a correction?

The Form 4/A is a correction, not a new trade. A footnote states the stock award was omitted from the original filing due to a clerical error, and this amendment updates the disclosure to include that previously granted award.

How many Enhabit (EHAB) shares does Jeanne Kalvaitis hold after the reported award?

After receiving the 6,724-share stock grant, Jeanne Kalvaitis directly holds 61,875 shares of Enhabit common stock. This total reflects her updated ownership position following inclusion of the previously omitted award in the amended Form 4/A.

Was Jeanne Kalvaitis’s Enhabit (EHAB) transaction an open-market purchase or a stock grant?

The transaction was a stock grant, not an open-market purchase. It is coded as an “A” transaction, described as a grant, award, or other acquisition, with 6,724 common shares received at a value of $13.61 per share.

What role does Jeanne Louise Kalvaitis hold at Enhabit (EHAB)?

Jeanne Louise Kalvaitis serves as Enhabit’s Executive Vice President of Hospice Operations. Her position is disclosed in the insider data, and the amended Form 4/A reports an equity award tied to her role as a company officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kalvaitis Jeanne Louise

(Last)

(First)

(Middle)

6688 N. CENTRAL EXPRESSWAY

SUITE 1300

(Street)

DALLAS

75206

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Enhabit, Inc. [ EHAB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP of Hospice Operations

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)
03/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/06/2026		A		6,724⁽¹⁾	A	$13.61	61,875	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Due to a clerical error, this award was omitted from the original filing.

Remarks:

	/s/ Sarah W. Braley, Attorney in Fact	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR